By Natalie Kostelni – Reporter, Philadelphia Business Journal
The University of Pennsylvania has signed a lease on 150,000 square feet at Discovery Labs in King of Prussia and will use the space for its gene therapy program.
The space is in two buildings off Swedeland Road in what had been previously built and used by GlaxoSmithKline and later sold to MLP Ventures, a Radnor real estate company that is marketing the campus to life sciences and related tenants.
Two floors of the space will be used to expand Penn Vector Core. Vectors are used to deliver gene therapies in patients with conditions resulting from missing or malfunctioning genes.
Led by gene therapy expert Dr. James M. Wilson, Penn’s gene therapy program has been responsible for breakthrough therapies for a variety of disorders. In early 2019, The National Institutes of Health renewed a five-year contract with Penn’s gene therapy program and was awarded $13 million to support the advancement of gene-therapy research at the clinic.
Full story: https://tinyurl.com/tce4tbw
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.